S.Res. 161 · 111th Congress
A resolution recognizing June 2009 as the first National Hereditary Hemorrhagic Telangiecstasia (HHT) month…
Full title
A resolution recognizing June 2009 as the first National Hereditary Hemorrhagic Telangiecstasia (HHT) month, established to increase awareness of HHT, which is a complex genetic blood vessel disorder that affects approximately 70,000 people in the United States.
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Agreed to without a recorded vote. It was agreed to by voice vote or unanimous consent, which don't record how each member voted.
D
JohnsonSponsor7 cosponsors · 4 D, 3 R
0 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
- Senate Introduced May 21, 2009
- Senate Passed May 21, 2009
Expresses support for the designation of June 2009 as National Hereditary Hemorrhagic Telangiecstasia (HHT) month.
What it does: CRS summary · Passed Senate without amendment · May 21, 2009
(This measure has not been amended since it was introduced. The summary of that version is repeated here.)
Expresses support for the designation of June 2009 as National Hereditary Hemorrhagic Telangiecstasia (HHT) month.
Recognizes: (1) the need to pursue research to find better treatments and a cure for HHT; (2) the HHT Foundation International as the only U.S. advocacy organization working to find a cure for HHT while saving the lives and improving the well-being of individuals and families affected; (3) the importance of comprehensive care centers in providing complete care and treatment for HHT patients; (4) that stroke, lung, and brain hemorrhages can be prevented through early diagnosis, screening, and treatment of HHT; (5) that severe hemorrhages in the nose and gastrointestinal tract can be controlled through intervention and that heart failure can be managed through proper diagnosis and treatments of HHT; and (6) that a leading medical and academic institution estimated that $6.6 billion of one-time health care costs can be saved through aggressive management of HHT in the at-risk population.
Acknowledges the need to identify the approximately 90% of the HHT population that has not yet been diagnosed and that is at risk for death or disability due to sudden rupture of the blood vessels in major organs in the body.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: A resolution recognizing June 2009 as the first National Hereditary Hemorrhagic Telangiecstasia (HHT) month, established to increase awareness of HHT, which is a complex genetic blood vessel disorder that affects approximately 70,000 people in the United States.
Latest action (May 21, 2009): Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S5885; text as passed Senate: CR S5885; text of measure as introduced: CR S5877)
Policy area: Health · Origin: Senate · Introduced: May 21, 2009
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
- Senate Introduced May 21, 2009
- Senate Passed May 21, 2009
No recorded floor vote found.